FDA Inspection 1074148 — Corden Pharma Switzerland LLC
The FDA completed an inspection of Corden Pharma Switzerland LLC on Nov 2, 2018 in Liestal. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 2, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Liestal (Switzerland)